New paper lays out problems of developing gene-edited GM crops
By Claire Robinson,
GM Watch
| 08. 30. 2023
Announcing the passing into law of the Genetic Technology Act, which removes regulatory safeguards around a whole subclass of GMOs, notably those produced using gene editing, the Westminster government breathlessly enthused that the UK had now joined “Argentina, the US, Australia and Japan”, which “have already enacted similar legislation, driving innovation on a global scale and helping fight the greatest challenges facing the world”.
I can’t pretend that GMWatch was waiting with bated breath for the “new GM”-based “innovation on a global scale” that was supposed to be pouring out of these countries, especially given the dismal performance and fate of the handful of gene-edited crops that they've released.
But the history of GM crops has settled into a pattern of hyped reports of supposed successes continuing for a good few years before they give way to sad tales of technology failure. So at this early stage of the “new GM” journey, we were expecting something reasonably upbeat about gene-edited GM crops from these deregulatory pioneering countries.
What we didn’t expect just yet is the catalogue of abject failure...
Related Articles
By Scott Solomon, The MIT Press Reader | 02.12.2026
Chris Mason is a man in a hurry.
“Sometimes walking from the subway to the lab takes too long, so I’ll start running,” he told me over breakfast at a bistro near his home in Brooklyn on a crisp...
By Diaa Hadid and Shweta Desai, NPR | 01.29.2026
MUMBRA, India — The afternoon sun shines on the woman in a commuter-town café, highlighting her almond-shaped eyes and pale skin, a look often sought after by couples who need an egg to have a baby.
"I have good eggs,"...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Staff, ScienceDaily | 01.05.2026
Scientists at UNSW Sydney have developed a new form of CRISPR technology that could make gene therapy safer while also resolving a decades-long debate about how genes are switched off. The research shows that small chemical markers attached to DNA
...